Third triMS.online conference

Management challenges in MS: immunology

Third triMS.online conference, February 2020

The latest research and clinical insights on Management challenges in MS: immunology
'Hot topic' debate on the motion ‘Anti-viral drug prophylaxis should be given routinely to patients with MS who have grade 3 or 4 lymphopenia’

About this event

Thanks to the support of our sponsors the third triMS.online conference, Management challenges in MS: immunology, took place on 13 February 2020. Chaired by Laura Airas, University of Turku, Finland, this conference:

showcases the latest research and clinical insights on Management challenges in MS: immunology
includes a ‘hot topic’ debate on the motion ‘Anti-viral drug prophylaxis should be given routinely to patients with MS who have grade 3 or 4 lymphopenia’

Available therapies for MS have diverse mechanisms of action and their effects on the immune system can lead to management challenges. The clinical implications of changes to the immune response and any subsequent effects are important to understand and provided the focus of this programme.

Video

Chapters

0:01:38	Introductory teaching session
0:30:20	Chair's opening remarks
0:34:36	Keynote presentation: Lymphopenia: its interpretation and management in MS
0:54:59	Immunological targets in MS (memory B cells and plasma cells)
01:03:07	Immune reconstitution therapies
01:12:45	Neurofilament monitoring in the management of MS
1:24:36	Vaccinations in people with MS
1:36:35	Pharmacovigillance in the modern era
1:49:58	Current controversy

Scientific programme

13:00	Conference open Free time to explore the exhibition stands, poster hall and platinum sponsor theatre
13:30	Introductory teaching session Lymphopenia made simple Gavin Giovannoni
14:00	Platform opens and introduction Chair: Laura Airas, Finland
14:05	Keynote presentation Lymphopenia: its interpretation and management in MS Joanne Jones
14:20	Immunological targets in MS (memory B cells and plasma cells) Martin Weber
14:30	Immune reconstitution therapies Jan Lünemann
14:40	Company-sponsored satellite Exploring early intervention in MS F. Hoffmann-La Roche
15:00	Break Free time to explore the exhibit and poster halls
15:20	Neurofilament monitoring in the management of MS Jan Lycke
15:30	Vaccinations in people with MS Saúl Reyes
15:40	MS and opportunistic infections in the current treatment era Angela Vidal-Jordana
15:50	Pharmacovigilance in the modern era Stephen Reddel
16:00	Debate motion ‘Anti-viral drug prophylaxis should be given routinely to patients with MS who have grade 3 or 4 lymphopenia’ For: Farrah Mateen Against: Noriko Isobe
	Moderators’ introduction and audience vote on the motion Laura Airas, Finland Gavin Giovannoni, UK Position statements Expert panel discussion Summing up
16:50	Conclusion and thanks Chair: Laura Airas
17:00	Meeting close

Resources

	Management challenges in MS: immunology 0.14MB PDF
	Speaker biographies 0.57MB PDF
	Introductory teaching session: Lymphopenia made simple 3MB PDF
	Immunology Q&As 0.3MB PDF

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_D3ZC0HSF33	2 years	This cookie is installed by Google Analytics.
_gat_gtag_UA_45336067_7	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
vuid	2 years	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.

Management challenges in MS: immunology

About this event

Video

Chapters

Scientific programme

Conference open

Introductory teaching session

Lymphopenia made simple

Platform opens and introduction

Keynote presentation

Lymphopenia: its interpretation and management in MS

Immunological targets in MS (memory B cells and plasma cells)

Immune reconstitution therapies

Company-sponsored satellite

Exploring early intervention in MS

Break

Neurofilament monitoring in the management of MS

Vaccinations in people with MS

MS and opportunistic infections in the current treatment era

Pharmacovigilance in the modern era

Debate motion

‘Anti-viral drug prophylaxis should be given routinely to patients with MS who have grade 3 or 4 lymphopenia’

Moderators’ introduction and audience vote on the motion

Position statements

Expert panel discussion

Summing up

Conclusion and thanks

Meeting close

Resources

Management challenges in MS: immunology

Speaker biographies

Introductory teaching session: Lymphopenia made simple

Immunology Q&As